[The efficacy of treating glomerulonephritis patients with a hematuria component].
A clinical evaluation was carried out of treatment efficacy of patients suffering of glomerulonephritis with hematuria component. membrane stabilizing therapy including unithiol, dimephosphon (delagil) and alpha-tocopherol acetate. Duration of this treatment was 1 month; 2 months--with alpha-tocopherol and delagil; 6 months--with delagil. TREATMENT was carried out in 80 patients. Six-month follow-up was evaluated in 62 patients. In 48 patients the treatment was effective as concerns proteinuria and in 4--only hematuria. Comparing the results of such treatment with indomethacin treatment where a positive dynamics was observed in 10 of 38 patients and only in 2 patients improvement concerned proteinuria and erythrocyturia. membrane stabilizing therapy is the method of choice in comparison with traditional indomethacin treatment.